NCT07040982

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-12-17Est. Completion: 2029-06-09

Enrollment target: 30 participants

Locations

City of Hope Medical center, Duarte, California, United States

Other microbiome trials you might be interested in

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsPhase 3Recruiting

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor…

Birmingham, United StatesEst. completion Jul 1, 2028

View Trial →

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic LeukemiaPhase 2Recruiting

Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Adult L1 Acute Lymphoblastic LeukemiaAdult L2 Acute Lymphoblastic Leukemia

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.